We’re excited to announce that the PiezoXpert® 4m is now available for clinical use across Australia and New Zealand.
For years, the PiezoXpert® has been trusted by embryologists and researchers for precise, low-trauma piezo micromanipulation — supporting techniques like ICSI and assisted hatching with minimal mechanical stress on delicate cells. With the launch of the PiezoXpert® 4m, that same trusted performance is now backed by clinical certification, making it ready to move from the research bench into everyday clinical workflows.
What This Means for Your Lab
The PiezoXpert® 4m brings the reliability embryologists already know into a clinical setting, offering:
- Gentle, precise manipulation — piezo-driven technology that reduces mechanical stress on oocytes and embryos
- TGA Approved — validated for use in accredited clinical IVF and embryology settings
- Consistent, repeatable results — the same core performance that has made PiezoXpert® a familiar name in research labs
The Research Version Isn’t Going Anywhere
If your lab relies on the original PiezoXpert® research version, nothing changes — it remains fully available and supported alongside the new PiezoXpert® 4m. Whether you’re running fundamental research or need a clinically validated solution, there’s now a PiezoXpert® to match your setting.
Ready to Learn More?
Whether you’re considering an upgrade to clinical-grade piezo manipulation or simply want to understand how the PiezoXpert® 4m compares to the research model, our team is here to help you find the right fit for your lab.
Get in touch with Scope Scientific today to arrange a demonstration or discuss how the PiezoXpert® 4m can support your clinic’s next step forward.
